Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Helius Medical Technologies Inc HSDT

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing... see more

Recent & Breaking News (NDAQ:HSDT)

Helius Medical Technologies, Inc. Announces Addition of P3 Health As New Authorized PoNS Treatment(TM) Clinic in Toronto, Canada

GlobeNewswire November 19, 2019

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook

GlobeNewswire November 12, 2019

Helius Medical Technologies, Inc. Announces Update on US Regulatory Strategy Following Pre-Submission Meeting with FDA

GlobeNewswire October 24, 2019

Helius Medical Technologies to Release Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019

GlobeNewswire October 1, 2019

Helius Medical Technologies, Inc. and HealthTech Connex Announce Grand Opening of Canada's Fifth PoNS Treatment(TM) Clinic

GlobeNewswire September 25, 2019

Helius Medical Technologies, Inc. Announces Addition of a New PoNS(TM) Clinic in Quebec City, Canada

GlobeNewswire September 13, 2019

Helius Medical Technologies, Inc. Provides a Business Update on Clinical Experience to Date in Canada

GlobeNewswire August 28, 2019

Helius Medical Technologies, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook

GlobeNewswire August 8, 2019

Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2019 Annual Meeting of Stockholders

GlobeNewswire July 12, 2019

Helius Medical Technologies to Release Second Quarter of Fiscal Year 2019 Financial Results on August 8, 2019

GlobeNewswire July 2, 2019

Helius Medical Technologies to talk science behind PoNSTM device at Rehab Week

Canada NewsWire June 20, 2019

Helius Medical Technologies, Inc. Provides a Business Update on FDA Strategy

GlobeNewswire June 18, 2019

Helius Medical Technologies, Inc. Announces Scientific Publication Confirming Tongue Stimulation with PoNS(TM) Alters Brain Activity

GlobeNewswire June 11, 2019

Helius Medical Technologies to Present at the JMP Securities Life Sciences Conference

GlobeNewswire June 7, 2019

Helius Medical Technologies, Inc. Announces Addition of Three New PoNS(TM) Authorized Clinics in Canada

GlobeNewswire June 5, 2019

Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook

GlobeNewswire May 9, 2019

Helius Medical Technologies Announces Closing of Final Tranche of Private Placement

GlobeNewswire December 29, 2017

Helius Medical Technologies Announces Closing of Second Tranche of Private Placement

GlobeNewswire December 28, 2017

Helius Medical Technologies Announces Closing of First Tranche of Private Placement

GlobeNewswire December 22, 2017

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Helius Medical Technologies, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire December 11, 2017